59 - Prospective Evaluation of Procedural Factors Related to False Negative Fluorescence In-Situ Hybridization (FISH) in Patients with Extrahepatic Cholangiocarcinoma
63 - Treatment of Exocrine Pancreatic Insufficiency in Patients with Chronic/Recurrent Acute Pancreatitis Improves Treatment Satisfaction and Decreases Healthcare Utilization: Interim Findings from the PACT-CP Registry
10 - Association Between Cold Snare Polypectomy Rate (CSPR) and Existing Endoscopist Quality Metrics: A New Frontier in Colonoscopy Quality Measurement?
48 - Implementation of a Digital Cancer Risk Assessment Tool and Genetic Testing Program in Gastroenterology Practices Throughout the US Identifies Inherited Cancer Susceptibility Syndromes in 15.6% of Patients Tested
49 - Sessile Serrated Lesion Detection Rate in Individuals with Positive Fecal Immunohistochemical Test Undergoing Colonoscopy: Results from a Large Nationwide Veterans Affairs Database
50 - Use of Mechanical Enhanced Colonoscopy to Improve Polyp Detection During Colorectal Cancer Screening: A Preliminary Results of Real-World Healthcare Database Analysis
51 - Lower Incidence of Gastrointestinal Cancers in Sodium Glucose Co-Transporter-2 Inhibitor-Treated Patients With Type 2 Diabetes Mellitus: A Population-Based Cohort Study in the United States
54 - Next-Generation Multitarget Stool DNA Test for Colorectal Cancer Screening: A Prospective Clinical Validation Study (BLUE-C) (Late-Breaking Abstract)
Location: Ballroom B
Late Breaking Abstract Presenter: Thomas F. Imperiale, MD – Indiana University Medical Center
Oral Paper PresentationAnnual Scientific Meeting
Diversity, Equity, Inclusion
Monday, Oct 23rd
ON DEMAND RECORDING (Must purchase Bonus Sessions to have access)
V3 - Biliary Reconstruction for High Grade Bile Leak: A Bidirectional Approach
Location: Ballroom CD
Presenting Author - Endoscopy Video Forum: Rebecca Sullivan, MD – University of Alabama at Birmingham
Endoscopy Video ForumAnnual Scientific Meeting
Monday, Oct 23rd
5:10 PM – 5:20 PM PT
V4 - Bridging the Gap: Successful Endoscopic Ultrasound-Guided Gastrojejunostomy with a Lumen-Apposing Metal Stent Placement in the Setting of Malignant Ascites
Location: Ballroom CD
Presenting Author - Endoscopy Video Forum: Shivantha Amarnath, MD – Staten Island University Hospital
Endoscopy Video ForumAnnual Scientific Meeting
Monday, Oct 23rd
5:20 PM – 5:30 PM PT
V5 - A Case of Endoscopic Repair of Tracheoesophageal Fistula With Septal Occluder Device
Location: Ballroom CD
Presenting Author - Endoscopy Video Forum: Myunghoon Kim, BS, MD – Penn State Milton S. Hershey Medical Center
25 - Efficacy and Safety of the Selective Sphingosine 1-Phosphate Receptor Modulator, Etrasimod, in Adult Patients With Eosinophilic Esophagitis: Primary Results from the Phase 2 VOYAGE Study
21 - Immune-Based Personalized Elimination Diet for the Treatment of Irritable Bowel Syndrome: A Double-Blind Randomized Sham-Controlled Study
Location: Ballroom A
Presenting Author: Tal Engel, MD – Gastroenterology Institute, Sheba Medical Center Tel Hashomer, Sackler School of Medicine, Tel Aviv University
Oral Paper PresentationAnnual Scientific Meeting
Tuesday, Oct 24th
9:00 AM – 9:10 AM PT
22 - Intra-Subject Reproducibility of Squeeze and Push Metrics in High-Resolution Anorectal Manometry: Assessing the Need for Multiple Attempts
Location: Ballroom A
Presenting Author: Ofer Fass, MD – Stanford University
Oral Paper PresentationAnnual Scientific Meeting
Wednesday, Oct 25th
8:50 AM – 9:00 AM PT
67 - Superiority of Nasal Spray Compared to Orally Administered Metoclopramide in Reducing Healthcare Costs in Treating Diabetic Gastroparesis Patients
52 - Interventions to Improve the Quality of Screening-Related Colonoscopy: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials
9 - Biologic and Small Molecule Therapies Are Not Associated with Increased Major Adverse Cardiovascular Events (MACE) in IBD: A Propensity Matched Cohort Study
32 - Pharmacokinetics, Exposure-Response Relationships, and Immunogenicity in Crohn’s Disease Patients with Ustekinumab Secondary Loss of Response Following Ustekinumab IV Re-Induction: Week 16 Results from the POWER Study
33 - Symptomatic Improvement Observed Within 2 Days of Etrasimod Induction Therapy: Results from ELEVATE UC 52 and ELEVATE UC 12 Studies in Patients with Ulcerative Colitis
34 - Early Symptomatic Improvement With Guselkumab Induction Treatment in Moderately to Severely Active Ulcerative Colitis: Results from the Phase 3 QUASAR Induction Study
35 - Risankizumab Induction Therapy in Patients WIth Moderately to Severely Active Ulcerative Colitis: Efficacy and Safety in the Randomized Phase 3 INSPIRE Study
69 - Efficacy of Guselkumab in Patients With Moderately to Severely Active Crohn’s Disease Not in Clinical Response at Week 12: Results From the GALAXI 1 Study
70 - Two-Year Efficacy and Safety of Mirikizumab Following 104 Weeks of Continuous Treatment: Interim Results From the LUCENT-3 Open-Label Extension Study
71 - Real-World Clinical Effectiveness and Safety of Vedolizumab and Ustekinumab in Bio-Naïve Patients With Complex Crohn’s Disease: Results from the EVOLVE Expansion Study
55 - Similar Efficacy of a Novel Bipolar Radiofrequency Ablation Knife to Monopolar Current Knife in Endoscopic Submucosal Dissection of Colonic Lesions: A Non-Inferiority Randomized Trial
58 - Successful EUS-Guided Pancreatic Cyst Chemoablation Safely Allows Reduction in the Intensity of Post Treatment Radiographic Surveillance: Long-Term Follow-Up of Randomized Prospective Data
Location: Ballroom A
Presenting Author: Wes Heinle, MPH – Penn State Health Milton S. Hershey Medical Center
Learning Luncheon 13: Cirrhosis Complications: Esophageal Varices, Ascites, Hepatic Encephalopathy: Update on the Current Management of the Decompensated Cirrhotic
15 - Impact of Pharmacologic Treatment for Alcohol Use Disorder on Mortality in Patients with Alcohol-Associated Liver Disease: Analysis From a United States Insurance Claims Database
17 - Seladelpar Treatment Resulted in Correlated Decreases in Serum IL-31 and Pruritus in Patients with Primary Biliary Cholangitis (PBC): Post-Hoc Results from the Phase 3 Randomized, Placebo-Controlled ENHANCE Study
39 - Plant-Based Meals Generate Lower Ammonia and Have a Unique Metabolomic Signature Compared to Meat-Based Meals Despite Similar Baseline Microbiome in Patients with Cirrhosis: A Randomized Clinical Trial
65 - Outcomes of Anti-Obesity Glucagon-Like Peptide 1 Agonists vs Revisional Endoscopic Sleeve Gastroplasty for Weight Regain After Laparoscopic Sleeve Gastrectomy: A Case-Control Real World Experience
Location: Ballroom B
Presenting Author: Firas Bahdi, MD (he/him/his) – David Geffen School of Medicine at University of California Los Angeles
Oral Paper PresentationAnnual Scientific Meeting
Oncology
Sunday, Oct 22nd
12:20 PM – 1:35 PM PT
Learning Luncheon 17: Hereditary Cancer and Genetic Syndromes: Essentials for the Boards
Changing the Course of Pancreatic Cancer: Identifying Innovation in Screening, Diagnosis, and Treatment (Berk Lecture)
Location: Ballroom B
Invited Lecturer: Amrita Sethi, MD – Columbia University Medical Center-NYP
Annual Scientific Meeting
Pediatrics
Wednesday, Oct 25th
9:50 AM – 10:00 AM PT
73 - Dupilumab Improves Histologic and Endoscopic Aspects of Eosinophilic Esophagitis (EoE), as Well as Rate of Weight Gain, in Children Aged 1 to <12 years: 52-week Results From the Phase 3 EoE KIDS Trial (Late-Breaking Abstract)
4 - Using Business Intelligence Data Analytics to Improve Scheduling of Urgent and Non-Urgent Gastroenterology Clinic and Endoscopies in a Large Safety-Net Hospital
Location: Ballroom B
Presenting Author: Jared Gloria, MD – Emory University School of Medicine, J. Willis Hurst Internal Medicine Residency
Oral Paper PresentationAnnual Scientific Meeting
Tuesday, Oct 24th
2:15 PM – 2:25 PM PT
46 - De-Implementation of Outdated Colonoscopy Surveillance Interval Recommendations Among Patients With Low-Risk Adenomas (DESIRE)
68 - Non-Invasive Vagal Nerve Stimulation Reduces Nausea Rescue Medication in Patients With Gastroparesis and Related Disorders, With Additional Benefits on Multiple Other Associated Symptoms